Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway
Abstract Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths worldwide. The majority of patients are diagnosed in advanced disease stage. Bone metastasis is the most frequent complication in NSCLC resulting in osteolytic lesions. The perfect balance between bone-res...
Main Authors: | Simona Taverna, Marzia Pucci, Marco Giallombardo, Maria Antonietta Di Bella, Mariacarmela Santarpia, Pablo Reclusa, Ignacio Gil-Bazo, Christian Rolfo, Riccardo Alessandro |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-03460-y |
Similar Items
-
Exosome-mediated drug resistance in cancer: the near future is here
by: Marco Giallombardo, et al.
Published: (2016-09-01) -
Exosomes biology: Function and clinical implications in lung cancer
by: Martin Frederik Dietrich, et al.
Published: (2017-01-01) -
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis
by: Stefania Raimondo, et al.
Published: (2019-01-01) -
Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and Matrix Metalloproteinases
by: Christopher Platen, et al.
Published: (2018-01-01) -
Unexpected responses to EGFR inhibition in NSCLC
by: Giulia M. Stella, et al.
Published: (2015-01-01)